Chongqing Taiji Industry's subsidiary, adrenaline hydrochloride injection, has passed the consistency evaluation of generic drugs.
Tai Chi Group (600129.SH) announced that its controlling subsidiary, Southwest Pharmaceutical Co., Ltd. (referred to as Southwest Pharmaceutical), recently received the "Drug Supplementary Application Approval Notice" from the National Medical Products Administration regarding Adrenaline Hydrochloride Injection. Southwest Pharmaceutical's Adrenaline Hydrochloride Injection has passed the evaluation of generic drug quality and efficacy consistency. This drug is mainly used for severe respiratory distress caused by bronchospasm, can quickly relieve allergic shock caused by drugs, and can also be used to prolong the action time of local anesthetics.
Chongqing Taiji Industry (600129.SH) announced that its holding subsidiary, Southwest Pharmaceutical Co., Ltd. (referred to as Southwest Pharmaceutical), has received the "Drug Supplementary Application Approval Notice" for the adrenaline hydrochloride injection from the National Medical Products Administration. The adrenaline hydrochloride injection of Southwest Pharmaceutical has passed the generic drug quality and efficacy consistency evaluation. This drug is mainly used for severe respiratory distress caused by bronchospasm, can quickly relieve allergic shock caused by drugs, and can also be used to prolong the duration of local anesthetics.
Related Articles
CHEVRON (02285) spent approximately HK$228.89 million on repurchasing 150,000 shares on June 10th.
KINGDEE INT'L (00268) spent HKD 7.2 million to repurchase 1 million shares on June 10th.
POU SHENG INT'L (03813) had a net comprehensive operating income of 1.457 billion yuan in May, a year-on-year decrease of 2.7%.
CHEVRON (02285) spent approximately HK$228.89 million on repurchasing 150,000 shares on June 10th.
KINGDEE INT'L (00268) spent HKD 7.2 million to repurchase 1 million shares on June 10th.
POU SHENG INT'L (03813) had a net comprehensive operating income of 1.457 billion yuan in May, a year-on-year decrease of 2.7%.
RECOMMEND
